Retinoic acid modulates the cell-cycle in fetal rat hepatocytes and HepG2 cells by regulating cyclin-cdk activities

Liver International

Volumn 23, Issue 3, 2003, Pages 179-186

  Alisi, A ^a   Leoni, Silvia ^a   Piacentani, A ^a   Conti Devirgiliis, L ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cell cycle inhibitors; Cyclin A E cdk2; Cyclin D1 cdk4; Hepatocytes; Retinoic acid

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; MYC PROTEIN; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN P16; PROTEIN P21; PROTEIN P27; RETINOIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME ACTIVITY; FEMALE; FETUS; FETUS CELL; HUMAN; LIVER CELL; MALE; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TUMOR CELL LINE; TUMOR GROWTH;

EID: 0142061469     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2003.00829.x     Document Type: Article

References (38)

1. Sherr C J. G1 phase progression: cycling on cue. Cell 1994; 79: 551-6.
2. Morgan D O. Cyclin-dependent kinases: engines, clocks, microprocessors. Annu Rev Cell Dev Biol 1997; 13: 261-91.
3. Sherr C J, Roberts J M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-12.
4. Montagnoli A, Fiore F, Eytan E, et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999; 13: 1181-9.
5. Yew P R. Ubiquitin-mediated proteolysis of vertebrate G1-and S-phase regulators. J Cell Physiol 2001; 187: 1-10.
6. Desalle L M, Pagano M. Regulation of G1 to S transition by the ubiquitin pathway. FEBS Lett 2001; 490: 179-89.
7. Pestell R G, Albanese C, Reutens A T, et al. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Rev 2000; 20: 501-34.
8. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000; 33: 261-74.
9. Sporn M B, Roberts A B, Goodman D S. The Retinoids: Biology, Chemistry and Medicine, 2nd edn. New York: Academic Press, 1994; 387-630.
10. Lotan R. Retinoids in cancer chemioprevention. FASEB J 1996; 10: 1031-9.
11. Hudson L G, Santon J B, Glass C K, et al. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell 1990; 62: 1165-75.
12. Liu M, Iavarone A, Freedman L P. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 1996; 271: 31723-8.
13. Gill P S, Espina B M, Moudgil T, et al. All-trans retinoic acid for treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia 1994; 8: S26-32.
14. Lovat P E, Irving H, Annichiarico-Petruzzelli M, et al. Retinoids in neuroblastoma theraphy: distinct biological properties of 9-cis and all-trans-retinoic acid. Eur J Cancer 1997; 33: 2075-80.
15. Baj G, Arnulfo A, Deaglio S, et al. Retinoids in breast cancer prevention and treatment. A review of the literature. Eur J Gynaecol Oncol 2000; 4: 411-5.
16. Texeira C, Pratt M A. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 1997; 11: 1191-202.
17. Yen A, Roberson M S, Varvayanis S, et al. Retinoic acid-induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) activation is needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 1998; 58: 3163-71.
18. Matsuo T, Thiele C J. P27 kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 1998; 16: 3337-43.
19. Langefeld J, Kiyokawa H, Sekula D, et al. Posttraslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci USA 1997; 94: 12070-4.
20. Baldassarre G, Boccia A, Bruni P, et al. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. Cell Growth Diff 2000; 11: 517-23.
21. Falasca L, Favale A, Serafino A, et al. The effect of retinoic acid on the reestablishment of differentiated hepatocyte phenotype in primary culture. Cell Tissue Res 1998; 293: 337-47.
22. Falasca L, Favale A, Gualandi G, et al. Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype in different fractions of cultured fetal rat hepatocytes. Hepatology 1998; 28: 727-37.
23. Falasca L, Marcellini P, Ara C, et al. Growth inhibition and induction of specific hepatic phenotype expression by retinoic acid in HepG2 cells. Anticancer Res 1999; 19: 3283-92.
24. Conti Devirgiliis L, Dini L, Di Pierro A, et al. An improved non-perfusion method for the isolation and purification of rat fetal and neonatal hepatocytes. Cell Mol Biol 1981; 27: 687-94.
25. Lowry O H, Rosebrough N T, Farr A L, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
26. Tsutumi A, Shiota G, Yamazaki H, et al. Accelerated growth of hepatocytes in association with up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor. Biochem Biophys Res Commun 2000; 278: 229-35.
27. Naderi B S, Blomhoff H K. Retinoic acid prevents phosphorylation of pRb in normal human lymphocytes: regulation of cyclin E, cyclin A, and p21. Blood 1999; 94: 1348-58.
28. Spinella M J, Sarah J F, Sekula D, et al. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J Biol Chem 1999; 274: 22013-8.
29. Hsu S L, Chen M C, Chou Y H, et al. Induction of p21 (Cip/Waf1) and activation of p34 (cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cells Res 1999; 248: 87-96.
30. Amos B, Lotan R. Retinoid-sensitive cells and cell lines. Meth Enzymol 1990; 190: 217-25.
31. Atencia R, Garcia-Sanz M, Unda F, et al. Apoptosis during retinoic induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res 1994; 214: 663-7.
32. Kinoshita A, Wanibuchi H, Imaoka S, et al. Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21 (WAF1/Cip1), cyclin D1 and Ogg1. Carcinogenesis 2002; 23: 341-9.
33. Niu M Y, Menard M, Reed J C, et al. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathways in breast cancer cells. Oncogene 2001; 20: 3506-18.
34. Sakai K, Suzuki K, Tanaka S, et al. Up-regulation of cyclin D1 occurs in apoptosis of immature but not mature cerebellar granule neurons in culture. J Neurosci Res 1999; 58: 396-406.
35. Timsit S, Rivera S, Ouaghi P, et al. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci 1999; 11: 263-78.
36. Li Z, Hromchak R, Bloch A. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation. Biochim Biophys Acta 1997; 1356: 149-59.
37. Yin M B, Toth K, Cao S, et al. Involvement of cyclin D1-cdk5 overexpression and MCM3 cleavage in bax-associated spontaneous apoptosis and differentiation in an A253 human head and neck carcinoma xenograft model. Int J Cancer 1999; 83: 341-8.
38. Kaptein J S, Lin C K E, Wang C L, et al. Anti-IgM mediated regulation of c-myc and its possible relationship to apoptosis. J Biol Chem 1996; 271: 18875-84.